NGM Biopharmaceuticals, Inc. - stock earnings
NGM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -27.7 million USD | 165000 USD |
| 2023Q3 | -28.8 million USD | 582000 USD |
| 2023Q2 | -38.3 million USD | 1.4 million USD |
| 2023Q1 | -45.1 million USD | 2.2 million USD |
| 2022Q4 | -34.6 million USD | 18.2 million USD |
| 2022Q3 | -46.2 million USD | 7.9 million USD |
| 2022Q2 | -46.0 million USD | 8.3 million USD |
| 2022Q1 | -32.3 million USD | 20.9 million USD |
| 2021Q4 | -27.2 million USD | 21.0 million USD |
| 2021Q3 | -28.9 million USD | 18.6 million USD |
| 2021Q2 | -36.7 million USD | 16.8 million USD |
| 2021Q1 | -27.5 million USD | 21.6 million USD |
| 2020Q4 | -28.0 million USD | 19.8 million USD |
| 2020Q3 | -29.8 million USD | 23.5 million USD |
| 2020Q2 | -25.6 million USD | 19.8 million USD |
| 2020Q1 | -19.1 million USD | 24.4 million USD |
| 2019Q4 | -15.9 million USD | 31.1 million USD |
| 2019Q3 | -10.9 million USD | 21.6 million USD |
| 2019Q2 | -7.7 million USD | 25.3 million USD |
| 2019Q1 | -8.3 million USD | 25.6 million USD |
| 2018Q4 | 14.2 million USD | 47.1 million USD |
| 2018Q3 | -7.5 million USD | 20.8 million USD |
| 2018Q2 | -3.2 million USD | 22.1 million USD |
| 2018Q1 | -3.9 million USD | 18.6 million USD |
| 2017Q4 | ? USD | 39.2 million USD |
| 2017Q2 | ? USD | 37.9 million USD |
| 2016Q4 | ? USD | 85.6 million USD |
NGM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -142.4 million USD | 4.4 million USD |
| 2022 | -159.1 million USD | 55.3 million USD |
| 2021 | -113.8 million USD | 77.9 million USD |
| 2020 | -94.0 million USD | 87.4 million USD |
| 2019 | -28.5 million USD | 103.5 million USD |
| 2018 | -493000 USD | 108.7 million USD |
| 2017 | -14.2 million USD | 77.1 million USD |
| 2016 | -6.9 million USD | 85.6 million USD |
NGM
Price: $1.54
52 week price:
Earnings Per Share: -1.73 USD
P/E Ratio: -0.83
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 175000
Market Capitalization: 128.5 million